首页> 外文OA文献 >The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium

【2h】

The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium

机译：Bivalirudin对肝素单疗法对透析患者进行经皮冠状动脉介入的比较安全性和有效性：密歇根州心血管联盟的蓝色横向蓝盾的见解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Devraj Sukul; Milan Seth; Theodore Schreiber; Akshay Khandelwal; Louis A. Cannon; Thomas A. LaLonde; Hitinder S. Gurm;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium [J] . Sukul Devraj, Seth Milan, Schreiber Theodore, Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions . 2017 ,第5期

机译：Bivalirudin对肝素单疗法对透析患者进行经皮冠状动脉介入的比较安全性和有效性：密歇根州心血管联盟的蓝色横向蓝盾的见解
2. The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [J] . Sukul Devraj, Seth Milan, Schreiber Theodore, Journal of interventional cardiology . 2017 ,第4期

机译：Abciximab与ePtifibatide对透析患者的比较安全性经皮冠状动脉介入：密歇根心血管联盟蓝色交叉蓝盾的见解（BMC2）
3. TCT-642 The Comparative Effectiveness and Safety of Cangrelor vs. In- lab Glycoprotein IIb/IIIa Inhibitor (GPI) in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [J] . Saifullah Siddiqui, Milan Seth, Devraj Sukul, Journal of the American College of Cardiology . 2018 ,第13期

机译：TCT-642在经皮冠状动脉介入的患者中，植物糖蛋白糖蛋白IIB / IIIA抑制剂（GPI）的比较效果和安全性：密歇根心血管联盟蓝色交叉蓝盾的见解（BMC2）
4. Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [O] . Devraj Sukul, Milan Seth, Simon R. Dixon, -1

机译：在接受经皮冠状动脉介入治疗的患者中术前使用口服P2Y12抑制剂的相关趋势和结果：密歇根州心血管协会（BMC2）的蓝十字蓝盾的见解
5. The Burgeoning Epidemic of Morbid Obesity in Patients Undergoing Percutaneous Coronary Intervention Insight From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium [O] . Buschur Michael E., Smith Dean, Share David, 2013

机译：从密歇根州心血管协会的蓝十字蓝盾接受经皮冠状动脉介入治疗的患者中病态肥胖的流行病流行

The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium

著录项

相似文献

相关主题

期刊订阅